The protection against liver fibrosis conferred by the hydroxysteroid, 17-beta dehydrogenase 13 (HSD17B13), is associated with reduced dihydropyrimidine dehydrogenase-mediated pyrimidine catabolism (Luukkonen et al., 2023). Here, DPYD is linked to Hepatic fibrosis.